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1. Introduction 
Tuberculosis (TB) infection is a major public health problem caused by Mycobacterium 
tuberculosis (M.tb). The present estimate is that one third of the world population harbors 
M.tb in a latent form (http://www.who.int), which may be reactivated when the host 
immune response is suppressed such as in HIV infection (Dye et al., 2005). Only 10% of the 
population which has been in contact with the pathogen develop overt clinical symptoms 
while roughly 90% of the infected persons contain the infection. A recent quantification of 
bacterial growth and death rates showed that M.tb replicates throughout the course of 
chronic TB infection in mice and is restrained by the host immune system (Gill et al., 2009). 
Unraveling the host immune response during primary and chronic/latent infection is 
therefore a major challenge. Prominent mechanisms of the host leading to protective 
immunity controlling tuberculosis and reactivation of infection are associated with T cells, 
macrophages, interferon- (IFN-), TNF, interleukin-12 (IL-12), nitric oxide (NO), reactive 
oxygen and reactive nitrogen intermediates (RNI), as reviewed (Cooper, 2009; Flynn, 2004; 
Flynn and Chan, 2001a; North and Jung, 2004). While IL-23 and IL-17 contribute to host 
resistance (Umemura et al., 2007), they do not seem essential to control acute TB infection 
(Khader et al., 2007). 
2. The TNF family  
TNF is the founder member of cytokine TNF-like superfamily (for review see (Locksley et al., 
2001; Ware, 2005; Watts, 2005). TNF is expressed by many different cell types including 
macrophages, dendritic cells, CD4+ and CD8+ T cells, B cells, but also by other cells such as 
www.intechopen.com
 
Understanding Tuberculosis – Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity 
 
236 
adipocytes, keratinocytes, mammary and colon epithelium, osteoblasts, or mast cells. TNF is 
first synthesized as a homotrimeric 26 kDa membrane bound protein or transmembrane TNF 
(tmTNF). After proteolytic cleavage by TNF-alpha converting enzyme (TACE), 17 kDa soluble 
TNF is released. Levels of circulating TNF in healthy individuals are nearly undetectable 
however they increase substantially in pathological situations. Lymphotoxin alpha is a 
member of TNF superfamily and structurally the closest TNF relative. It exists as a soluble 
homotrimer (LT3) or forms a membrane-bound heterotrimeric complex with the anchor LT. 
TNF, LT and LT genes are tightly clustered within 12kb inside the major 
histocompatibility complex locus on murine chromosome 17 (human 6), while the receptors 
(R), TNF-R1 and LTR genes are clustered on mouse chromosome 6 and human 
chromosome 13 (Nedospasov et al., 1986; Spies et al., 1986). Membrane-bound as well as 
soluble TNF interact with two receptors, TNFR1 (p55 in mouse, p60 in humans, CD120a) 
and TNFR2 (p75/p80, CD120b). TNFR1, the high affinity receptor for soluble TNF, is 
constitutively expressed in nearly all tissues and cell types. TNFR1 contains a protein 
module called “death-domain” which is essential for induction of apoptosis, as well as for 
other non-apoptotic functions (Locksley et al., 2001). The expression of TNFR2 is more 
restricted to lymphoid tissues (Chan et al., 2000). Soluble LT3 also binds and activates both 
TNFR1 and TNFR2, whereas membrane bound LT exerts its unique functions through the 
engagement of LTR (for review see Ware, 2005).  
Receptor ligation initiates signals through a complex cascade to activate the nuclear factor 
NFB, JNK-AP1 and p38 signaling axis resulting in activation of TNF-dependent program of 
gene expression (for review see (Grivennikov et al., 2006). Both TNR1 and TNFR2 are 
constitutively shed in substantial amounts in vivo and soluble TNF receptor shedding is 
likely to play an important role in regulating TNF activity under physiologic conditions 
(Pinckard et al., 1997). Macrophage infection by M.tb was shown to induce release of soluble 
TNFR2 that formed inactive TNF-TNFR2 complexes and reduced TNF bioactivity 
(Balcewicz-Sablinska et al., 1998). M. bovis BCG in vivo infection upregulates soluble TNFR1 
and TNFR2 release in the circulation following release of TNF (Garcia et al., 2000). 
Thus, tmTNF, soluble TNF and soluble LT3 appear to mediate both overlapping and 
distinct physiological responses in vivo. Their relative roles in inflammatory models and in 
host defense have not been fully unraveled, in large part due to the limitations in 
physiologically relevant in vivo models. Membrane-bound TNF mediates cellular responses 
such as apoptosis, proliferation, B cell activation, and some inflammatory responses. To 
date, the main evidence for an in vivo role for tmTNF has come from genetically modified 
mice expressing uncleavable membrane-bound TNF {Ruuls, 2001, Alexopoulou, 2006). 
While the role of TNF in controlling tuberculosis has been extensively studied using a panel 
of available mouse models (Bean et al., 1999; Kaneko et al., 1999; Roach et al., 2002; Zganiacz 
et al., 2004), the role of LT3 had to be implicated indirectly from the comparative 
phenotypes of mice deficient for LT versus LT or TNFR1/TNFR2 versus TNF and 
therefore remained much less defined. 
3. Non-redundant role of TNF to control mycobacterial infection 
Macrophages, DC and epithelial cells are among the first cells encountering M.tb bacilli in 
the airway. Phagocytosis induces the transcriptional machinery resulting in the secretion of 
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several proinflammatory cytokines, chemokine, expression of costimulatory molecules and 
effector molecules including nitric oxide which has mycobactericidal activity (Figure 1). 
Mycobacterial proteins are degraded and presented by class II proteins to the T cell receptor 
inducing clonal activation of CD4 T cells. IFN derived from T cells and NK or NKT cells is a 
potent activator of APCs, enhancing the killing of M.tb and presentation of mycobacterial 
peptide to T cells. The concerted action of cytokines and chemokines leads to accumulation 
of activated macrophages containing a few surviving bacilli surrounded by activated T cells, 
which constitutes the typical mycobacterial granuloma (Figure 1). Other cell types may 
participate in this process and include neutrophils, eosinophils, NK, NKT and mast cells and 
possibly -T cells (Cooper, 2009; Flynn and Chan, 2001a; North and Jung, 2004; Umemura 
et al., 2007).  
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Fig. 1. Macrophage and T cell activation, killing of TB bacilli and granuloma formation.  
Macrophages are activated by TB bacilli and produce cytokines and T cell activation. 
Activated macrophages are mycobactericidal, but a few bacilli escape. The cell activation 
induces lymphocyte recruitment orchestrated by chemokines leading to the formation of 
granulomas which contain the bacilli. Antibody neutralization of TNF or IFN or T cell 
depletion result in dissolution of the granuloma structure, rescue of surviving bacilli with 
dissemination of infection. 
Infection with the vaccine strain M. bovis BCG is well controlled in normal C57Bl/6 mice. 
However, the control of M. bovis BCG infection is TNF dependent as mice treated with anti-
TNF antibodies showed impaired granuloma formation and increased bacillus content 
(Kindler et al., 1989). Transgenic mice expressing soluble TNFR1-Fc fusion protein 
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neutralizing TNF and LT succumbed to M. bovis BCG infection (Garcia et al., 1997; Guler et 
al., 2005). Using the originally available TNF-LT double deficient mice (Eugster et al., 
1996), we showed that TNF and/or LT signaling is required to activate cells of the immune 
system (Jacobs et al., 2000). TNF-LT double deficient mice display high susceptibility and 
succumb to BCG infection between 8 and 10 weeks. The granuloma response was severely 
impaired with reduced T cell recruitment and macrophages expressed reduced inducible 
nitric oxide synthase (NOS2), a key mediator of antibacterial defense (Jacobs et al., 2000). We 
and others further compared the susceptibility of single TNF and LT deficient mice, and 
showed that both single gene deficient mice succumbed to M. bovis BCG infection, 
suggesting that both TNF and LT are necessary and non-redundant to control M. bovis 
BCG infection (Bopst et al., 2001). Reintroduction of LT as a transgene into TNF-LT 
double deficient mice prolonged survival but failed to restore resistance to M. bovis BCG 
(Bopst et al., 2001). 
Although M. bovis BCG is an attenuated strain, the absence of TNF or TNF signaling 
induced a phenotype essentially similar to an infection with virulent M.tb. Indeed, mice 
deficient for TNF (Bean et al., 1999; Kaneko et al., 1999; Roach et al., 2002; Zganiacz et al., 
2004), or TNF-R1 (Flynn et al., 1995), or mice treated with soluble TNFR1 or TNFR2 to 
neutralize TNF (Adams et al., 1995; Garcia et al., 1997; Smith et al., 2002) have poorly formed 
granulomas with extensive regions of necrosis and neutrophilic infiltration of the alveoli, 
and an inability to control mycobacterial replication upon infection with virulent M.tb 
strains. Bean et al. found comparable MHC class II and inducible nitric oxide synthase 
expression, serum nitrite levels, and normal activation of T cells and macrophages, while the 
organization of granulomas was clearly defective and not compensated by LT(Bean et al., 
1999) TNF was not required for granuloma formation, but rather for maintaining 
granuloma integrity indirectly by restricting mycobacterial growth within macrophages and 
preventing their necrosis in M. marinum-infected zebrafish (Clay et al., 2008). Similarly, in a 
murine model of M. bovis BCG infection, established hepatic granuloma showed a profound 
decrease in size and in their population of non-infected macrophages within 2-4 days of anti 
TNF treatment (Egen et al., 2008). 
As observed in M. bovis BCG infection studies, both TNF and LT seemed necessary to 
control infection with virulent H37Rv strain of M.tb (Roach et al., 2002; Roach et al., 2001). 
However, the very close mutual proximity of genes coding for TNF, LT and LT on mouse 
chromosome 17 raises the issue of collateral gene damage in mouse models employing 
targeted modifications of TNF/LT genomic locus. For example, independently generated 
mouse strains with TNF deficiency behave identically in a number of infection and stress 
models but demonstrate discrepant phenotypes with regard to the development of Peyer's 
patches, apparently due to differences in the configuration of the targeted locus (Kuprash et 
al., 2005). Based on published reports, both removal of a regulatory element controlling 
transcription of the LT genes and their compensatory upregulation by the actively 
transcribed neo resistance cassette can be envisioned. Since LT expression essential for the 
development of Peyer's patches has to be cell type specific and may be subject to 
autoregulatory feedback loops, concluding resolution of these discrepancies proved to be a 
technically challenging task.  
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Another example of collateral gene damage, probably more relevant to TB research, is 
dysregulation of TNF expression in LT knockout mice. Recently generated LT mice 
were fully capable of producing TNF at normal levels, whereas “conventional” LT KO 
animals displayed significant decrease in TNF synthesis in several critical types of 
leukocytes both in vitro and in vivo (Liepinsh et al., 2006). In conventional LT KO mice, 
TNF deficiency could be corrected by transgenic TNF expression (Alexopoulou et al., 1998). 
In agreement with the results of TNF promoter studies, the deficiency appears to be 
restricted to macrophages and neutrophils (Liepinsh et al., 2006). Defective TNF production 
has been noted, to various extent, by several published reports utilizing conventional LT 
KO mice (Bopst et al., 2001; Schluter et al., 2003). Once again, cell type-specific collateral 
damage to transcriptional initiation may be difficult to unambiguously discriminate from 
physiological mutual regulation of two closely related cytokines sharing some of their 
receptors. Nevertheless, any conclusions indicating an independent protective role of 
soluble LT in intracellular infections based on experiments with conventional LT KO 
mice should be taken with certain caution. Our recent study comparing “conventional” LT 
KO mice and LT KO mice during M.tb and M. bovis BCG infections demonstrated that 
LT might have a less essential role than anticipated for the control of acute infection, and 
the phenotype previously observed might indeed result at least in part from additional 
defects such as reduced TNF expression (Allie et al. 2010). 
4. Molecular mechanisms of mycobacterial killing/resistance 
Activation of macrophages and dendritic cells by M.tb induces several proinflammatory 
cytokines including TNF, LT and IL-12, and expression of costimulatory molecules that 
enhance antigen presentation and activation of T cells. Activated T cells produce TNF, IFN 
and LT inducing further activation of macrophages and likely other cells including stroma 
cells. Activated macrophages express NOS2, producing nitric oxide and reactive nitrogen 
intermediates (RNI), which are critical for killing and inhibiting growth of virulent M.tb and 
BCG (Chan et al., 1992; Garcia et al., 2000; MacMicking et al., 1995). 
Mycobacteria may inhibit phagosomes maturation and fusion with lysosomes, thereby 
escaping killing (Mwandumba et al., 2004; Russell et al., 1996; Sturgill-Koszycki et al., 1996; 
Xu et al., 1994). Activated macrophages recruit T cells to form granulomas, which contain 
bacterial growth. The granuloma is a dynamic structure, which requires a permanent signal 
from activated T cells and macrophages (Ehlers et al., 1999). Any perturbation of this 
signaling such as neutralization of TNF causes dissolution of granulomas (Kindler et al., 
1989) and allows reactivation and spread of infection (Figure 1). Activated T cells not only 
provide help, but acquire cytotoxic functions, which eradicate bacilli, although the relative 
contribution of CD4 versus CD8 cells to control TB infection is not fully established.  
In order to better understand the effect of TNF on intracellular replication of mycobacteria, 
we investigated the growth of the vaccine strain BCG in TNF deficient macrophages. M. 
bovis BCG infection resulted in logarithmic growth of the intracellular bacilli, while 
recombinant BCG-expressing TNF (BCG-TNF) led to bacillary killing associated with 
production of NO. Therefore, TNF contributes to the expression of NOS2 and to bacterial 
growth inhibition indirectly (Bekker et al., 2001).  
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IFN has been shown to be an essential component of immunity to tuberculosis. It 
activates infected host macrophages to directly inhibit the replication of M.tb (Flynn and 
Chan, 2001a). Although IFN-inducible NOS2 is considered the principal effector 
mechanism, other pathways exist. M.tb has developed several mechanisms to escape 
eradication including inhibition of phagosome maturation (Flynn and Chan, 2003). 
Mycobacteria, blocking Ca2+ signaling and phagosome maturation in human macrophages 
or inhibiting sphingosine kinase, may allow the escape from eradication in the phagocyte 
(Malik et al., 2000; Malik et al., 2001; Malik et al., 2003). The role of autophagy and 
ensuing inhibition of phagolysosome formation (Deretic, 2008) may be considered, as well 
as Coronin-1 inhibition as an alternative pathway to prevent phagosome maturation 
(Jayachandran et al., 2007).  
Defensins such as cathelicidin (LL37) have an important anti-mycobacterium activity in 
human macrophages. Liu and colleagues have reported that activation of Toll-like receptors 
(TLRs) up-regulates the expression of the vitamin D receptor and the vitamin D-1-hydrolase 
generating 1,25(OD)2D3, the active form of vitamin D, leading to induction of the 
microbicidal peptide cathelicidin and killing of intracellular M.tb in human macrophages 
(Liu et al 2006).  
Mycobacteria induce apoptosis of macrophages and cause the release of apoptotic vesicles 
that carry mycobacterial antigens to uninfected antigen-presenting cells, including dendritic 
cells which are indispensable for subsequent antigen cross-presentation through MHC-I and 
CD1b. This new pathway for presentation of antigens from a phagosome-contained 
pathogen illustrated the functional significance of infection-induced apoptosis in the 
activation of CD8 T cells specific for both protein and glycolipid antigens in tuberculosis 
(Schaible et al., 2003). 
Induction of TNF and other proinflammatory cytokines is mediated through several 
mycobacterial motives triggering different pattern recognition receptors, including TLR2, 
TLR4 or TLR9. However, while the control of acute TB infection was severely compromised 
in the absence of MyD88 (Feng et al., 2003; Fremond et al., 2004), TLR2, TLR4 and/or TLR9 
do not seem essential for the control of acute TB infection but may interfere in the control of 
chronic infection (Bafica et al., 2005; Drennan et al., 2004; Holscher et al., 2008). The MyD88 
pathway may thus contribute rather through IL-1R signaling to control acute TB (Fremond 
et al., 2007). TLR/MyD88 dependent signaling is also required for phagosome maturation 
(Blander and Medzhitov, 2004).  
In summary, TNF participates in resistance to mycobacteria in the following ways: (1) 
activation of macrophages, (2) induction of chemokines and cell recruitment, (3) activation 
of T cells, (4) killing by macrophages, T and other cells and (5) regulation of apoptosis and 
signals from TLR/MyD88/IL-1R pathway that contribute to the host response. Since 
separating the effects of these different TNF functions in vivo is presently difficult or 
impossible, a computational model was applied to understand specific roles of TNF in 
control of tuberculosis in a single granuloma. The model predicted that macrophage 
activation is a key effector mechanism for controlling bacterial growth within the 
granuloma, TNF and bacterial numbers represent strong contributing factors to granuloma 
structure, and TNF-dependent apoptosis may reduce inflammation at the cost of impaired 
mycobacterial clearance (Ray et al., 2009). 
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5. Membrane TNF biological activity controls acute M.tb infection 
Although a key role of TNF in controlling intracellular bacterial infections is uncontested, it 
is only recently that the specific function of membrane TNF has been appreciated. 
Membrane TNF is cleaved by the metalloproteinase-disintegrin TACE (TNF alpha 
converting enzyme) (Black et al., 1997) into the secreted, soluble trimeric TNF. Several 
functions of membrane TNF have been described, such as cytotoxicity, polyclonal activation 
of B cells, induction of IL-10 by monocytes, ICAM-1 expression on endothelial cells and liver 
toxicity (Decker et al., 1987; Grell et al., 1995; Kriegler et al., 1988; Ruuls et al., 2001). The 
transgenic expression of membrane TNF suggested an in vivo role of membrane TNF 
(Akassoglou et al., 1997). Olleros et al. investigated the resistance to mycobacterial infection 
in transgenic mice expressing a membrane TNF (12-10; -1; one substitution, K11E) under 
the control of proximal TNF promoter and on a TNF-LT deficient background. In this 
model membrane TNF had a fully protective effect against M. bovis BCG but only partial 
protective effect against M.tb infection (Olleros et al., 2002; Olleros et al., 2005). Mice with 
functional, normally regulated and expressed membrane-bound TNF represents a major 
advance and allowed interesting insights in the role of membrane TNF in lymphoid 
structure development and inflammation. Knock-in mice expressing the uncleavable1-
9,K11E TNF (Ruuls et al., 2001) and TNF-deficient mice (Marino et al., 1997) were compared 
in their resistance to mycobacterial infection. As previously reported for membrane TNF 
transgenic mice, we and others demonstrated that membrane TNF has important biological 
functions and substitutes soluble TNF to a large extent (Dambuza et al., 2008; Fremond et 
al., 2005; Saunders et al., 2005; Torres et al., 2005). Membrane TNF knock-in mice survived a 
M.tb aerosol infection for three months, were able to recruit and activate macrophages and T 
cells, generate granuloma and partially control mycobacterial infection in the early stage, 
unlike complete TNF deficient mice (Fremond et al., 2005; Saunders et al., 2005). However, 
during the chronic phase of infection membrane TNF knock-in mice demonstrated reduced 
bacterial clearance and succumbed to infection (Fremond et al., 2005). In another model of 
targeted mutagenesis in mice, the shedding of membrane TNF was prevented by deleting its 
cleavage site (Alexopoulou et al., 2006). Mice expressing non-cleavable and regulated 
Delta1-12 TNF allele partially controlled M. bovis BCG infection, with recruitment of 
activated T cells and macrophages and granuloma formation, while mice with complete 
TNF deficiency succumbed (Allie et al., 2008). It was confirmed that membrane TNF 
conferred partial protection against virulent M.tb infection and inter-crossing these mice 
with TNF-R1 or TNF-R2 KO mice showed that tmTNFxTNFR2 KO mice were very sensitive, 
essentially as much as TNF KO mice, while tmTNFxTNFR1 KO mice behaved more like 
tmTNF mice, suggesting that the protective effect of membrane TNF against acute M.tb 
infection is mediated through TNF-R2 signalling (Allie et al., 2008).  
Therefore data from the genetic mouse models suggest that membrane expressed TNF is 
sufficient and soluble TNF dispensable to control the first phase of acute TB infection. 
However, during the chronic phase membrane TNF alone is not sufficient and soluble TNF 
seems to be required to control chronic TB infection. The reason for the progressive loss of 
infectious control is unclear. As previously discussed, soluble TNF may be required to 
negatively control the Th1 type cytokines. This TNF function may become important during 
the chronic phase of infection by regulating excess production of IL-12 and IFN- by DC and 
T cells.  
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6. TNF in reactivation of TB infection 
Clinical tuberculosis in humans may be due to a primary infection or reactivation of latent 
controlled infection. Secondary immunosuppression due to HIV/AIDS is the most 
common cause of M.tb reactivation. In recent years, over a million patients received TNF 
neutralizing therapy for the treatment of severe rheumatoid arthritis, Crohn’s disease or 
severe psoriasis. The most common complication of TNF blockade has been the 
emergence of opportunistic infection and tuberculosis. Both reactivation of latent 
tuberculosis and increased susceptibility to new tuberculosis in patients without a clinical 
history of active TB infection was observed (Wallis, 2008). In some patients, neutralizing 
TNF antibody, infliximab, or soluble TNFR2-IgG1 Fc fusion protein, etanercept, yielded 
reactivation of latent TB within 12 weeks and overt clinical disease (Keane, 2005; Keane et 
al., 2001; Mohan et al., 2004), often with extrapulmonary disease manifestations 
(disseminated infection in lymph node, peritoneum and pleura). The frequency of 
tuberculosis in association with infliximab therapy was higher than the reported 
frequency of other opportunistic infections associated with this drug (Keane, 2005). 
Reactivation of latent tuberculosis and primary infection in patients treated with TNF 
inhibitors are still difficult to be clearly defined in many cases. Anti-TNF antibody may be 
more associated with latent TB reactivation than etanercept. The majority of etanercept-
associated cases of TB appears late (90% after 90 days of treatment) suggesting that these 
cases may have occurred as a result of the inability to control new M.tb infection while 
43% of infliximab associated cases of TB occurred during the first 90 days of treatment, 
indicating that they likely represent reactivation of latent infection (Wallis, 2008; Wallis et 
al., 2005). The reactivation of latent TB under TNF blocking therapy indicates that the 
normal immune system is able to control, but not able to eradicate a primary infection, 
and that TNF plays a role in the long term containment of residual M.tb in tissues. 
In order to study the factors leading to reactivation of chronic or chemotherapy controlled 
latent infection, several experimental models have been developed (Flynn, 2006). In the 
Cornell model, after an intravenous administration of M.tb H37Rv and treatment with 
pyrazinamide and isoniazide (INH) for 12 weeks, mice appear to have cleared the bacilli 
from organs, but a substantial proportion of animals spontaneously reactivate with acute 
disease upon cessation of chemotherapy. Since the original publication of the Cornell model 
a few variations have been reported (Botha and Ryffel, 2002; Flynn and Chan, 2001b). In the 
low-dose model, infection is exclusively controlled by the host in the absence of 
chemotherapy (Flynn and Chan, 2001b). Although considered to better reflect the human 
host response, bacterial numbers in the organs of these mice remain high during the chronic 
persistent phase of infection. To date, these models have yielded significant information on 
the immune effector mechanisms participating in latent or chronic persistent and reactivated 
tuberculosis.  
We established the first aerosol infection model of drug-induced latent and reactivated 
murine tuberculosis using rifampicin and isoniazide (Botha and Ryffel, 2002, 2003). In this 
model, latency was defined as almost undetectable levels of bacilli in mouse organs for a 
prolonged period of time. Reactivation of infection could be achieved by inhibiting nitric 
oxide synthase activity by aminoguanidine (Botha and Ryffel, 2002). Using this model, we 
showed that a 4 weeks rifampicin and isoniazide administration cleared infection as 
assessed by viable bacterial accounts in the organs in both wild-type and TNF deficient 
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mice. Upon cessation of therapy massive spontaneous reactivation of M.tb infection 
occurred within several weeks in TNF deficient mice with necrotic pneumonia and death, 
while wild-type mice displayed mild subclinical reactivation (Botha and Ryffel, 2003). This 
model allows studying the role of TNF neutralization in a reactivating infection in the 
presence of an established specific adaptive immune response.  
The role of soluble vs membrane TNF was then studied in this model (Figure 2 and 
unpublished data). Although TNF KO mice rapidly lost weight and had to be terminated 
within 6 weeks after the end of the antibiotic treatment with uncontrolled infection, tmTNF 
KI mice survived as wild-type mice. Therefore, membrane TNF suffices to provide some 
control of the M.tb infection after reduction of the bacterial burden by an antibiotic 
treatment, while complete absence of TNF results in rapid progression of the infection. 
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Fig. 2. Comparison of susceptibility of membrane TNF KI and conventional TNF KO 
reactivating, chronic M.tb infection.  
Wild-type, TNF KO and mTNF KI mice were infected with M.tb (ca 100 CFU i.n.) and 
treated for 4 weeks with rifampicin and isoniazid (day 14-42) to control the infection. TNF 
KO mice started to die 6 weeks after the end of the antibiotic treatment while all mTNF KI 
mice survived as wild-type mice. In parallel groups infected with M.tb but not treated with 
antibiotics TNF KO had to be killed at 3 wk, while 6 out of 8 mTNF KI survived with no 
marked body weight loss.  
7. Pharmacological TNF neutralization and TB control 
The experimental models of TB reactivation described above allow to test the potential risk 
of diverse TNF neutralizing therapies to induce reactivation of TB. Administration of 
neutralizing TNF antibody but not of soluble TNF receptor was able to reactivate 
experimental latent infection (Plessner et al., 2007). TNF neutralization resulted in marked 
disorganization of the tuberculous granuloma and to the enhanced expression of specific 
proinflammatory molecules. (Chakravarty et al., 2008). A computational approach 
suggested that TNF bioavailability following anti-TNF therapy is the primary factor for 
www.intechopen.com
 
Understanding Tuberculosis – Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity 
 
244 
causing reactivation of latent infection and that even very low level of soluble TNF is 
essential for infection control (Marino et al., 2007). 
Novel approaches to experimentally block soluble TNF are being tested in murine models of 
TB. One approach is to compete for natural TNF by the use of dominant negative mutant 
TNF (DN-TNF; see Figure 3) reported to block soluble TNF while sparing membrane TNF 
(Steed et al., 2003). In vivo, DN-TNF attenuated arthritis without suppressing innate 
immunity to Listeria monocytogenes (Zalevsky et al., 2007). Similarly, DN-TNF protected mice 
from acute liver inflammation, without compromising host control of M. bovis BCG and M.tb 
infections (Olleros et al., 2009). This was in contrast to TNFR2-IgG1 etanercept that inhibits 
murine soluble and membrane TNF as well as LT which severely compromised the host 
response to M.tb infection (Olleros et al., 2009). Another novel approach is an active 
immunization selectively targeting soluble TNF. Vaccination with a virus-like particle 
linked to a TNF N-terminal peptide resulted in high titers of autoantibodies against soluble 
TNF. It protected mice from arthritis without inducing reactivation of latent tuberculosis 
(Spohn et al., 2007), while immunization against the entire TNF molecule yielded enhanced 
reactivation of latent TB. This difference was attributed to recognition of only soluble TNF 
vs recognition of both transmembrane and soluble TNF by the elicited antibodies. Thus,  
LT1
TNF and LT responsive cell 
DN-TNF
LT
LTRTNFR1 TNFR2
TNF and LT  producing cell 
solTNF
tmTNF
TNFR1 TNFR2
LT
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TNFR2-Fc
 
Fig. 3. Mechanisms of action of dominant-negative-TNF (DN-TNF) biologics and soluble 
TNFR2-Fc (Etanercept). Left, DN-TNF, a mutated form of human solTNF with disrupted 
receptor binding interfaces eliminates solTNF by a subunit exchange mechanism, but is 
unable to interact with tmTNF and LT. Right, solTNF, tmTNF, LT and LT can be 
neutralized by Etanercept, inhibiting interaction with corresponding receptors. Thus,  
DN-TNF (XENP1595) inhibits solTNF receptor signaling without suppressing tmTNF- or 
LTα responses to TNFR1 and TNFR2, mediating inflammatory and immune responses 
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specifically targeting soluble TNF has the potential to be effective against inflammatory 
disorders while overcoming the risk of opportunistic infections associated with the currently 
available TNF antagonists. 
8. Conclusions and perspectives 
In conclusion, TNF is an essential mediator for the integrity of microbiocidal granulomas 
and the control of M.tb infection. Experimental tuberculosis infection of gene deficient mice 
has demonstrated the non-redundant contribution of several pro-inflammatory cytokines 
such as TNF, IL-12, IFN or IL-1 to the host response to M.tb infection (Flynn, 2006; 
Fremond et al., 2007). An important notion is the fact that latent mycobacterial infection can 
be reactivated by TNF neutralization. Sparing membrane TNF in neutralizing TNF therapy 
used in rheumatic arthritis or Crohn’s disease may diminish the infectious complications 
and reactivation of latent TB infection.  
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